drugset / Trial / NCT01868191

Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)

NCT01868191 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the present study is to assess before, as well as 6 and 12 months following a therapy with benfotiamine the influence of therapy on intraepidermal nerve fiber density (skin biopsy) and neuropathic symptoms and deficits in people with type 1 or 2 diabetes mellitus and diabetic sensomotoric neuropathy.

Timeline

Start
2013-07
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Benfotiamine Small molecule 300 mg —